Morgan Stanley Lowered Cardinal Finl (CFNL) Holding; Sunesis Pharmaceuticals (SNSS) Sellers Increased By 19.85% Their Shorts

September 10, 2017 - By Henry Gaston

Morgan Stanley decreased Cardinal Finl Corp (CFNL) stake by 38.58% reported in 2016Q4 SEC filing. Morgan Stanley sold 447,292 shares as Cardinal Finl Corp (CFNL)’s stock 0.00%. The Morgan Stanley holds 712,009 shares with $23.35M value, down from 1.16 million last quarter. Cardinal Finl Corp now has $958.45M valuation. It closed at $29.04 lastly. It is down 0.00% since September 10, 2016 and is . It has underperformed by 16.70% the S&P500.

Sunesis Pharmaceuticals Incorporated (NASDAQ:SNSS) had an increase of 19.85% in short interest. SNSS’s SI was 330,300 shares in September as released by FINRA. Its up 19.85% from 275,600 shares previously. With 67,100 avg volume, 5 days are for Sunesis Pharmaceuticals Incorporated (NASDAQ:SNSS)’s short sellers to cover SNSS’s short positions. The SI to Sunesis Pharmaceuticals Incorporated’s float is 2.93%. It closed at $2.16 lastly. It is down 8.33% since September 10, 2016 and is uptrending. It has underperformed by 8.37% the S&P500.

Among 4 analysts covering Sunesis Pharmaceuticals (NASDAQ:SNSS), 1 have Buy rating, 1 Sell and 2 Hold. Therefore 25% are positive. Sunesis Pharmaceuticals had 6 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Tuesday, July 18 by Cantor Fitzgerald. The firm earned “Sell” rating on Friday, July 24 by TH Capital. Cantor Fitzgerald downgraded the stock to “Hold” rating in Friday, July 24 report. Cantor Fitzgerald maintained Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) rating on Thursday, July 27. Cantor Fitzgerald has “Hold” rating and $300 target. On Friday, July 24 the stock rating was downgraded by Cowen & Co to “Market Perform”. Wells Fargo upgraded the shares of SNSS in report on Friday, July 29 to “Outperform” rating.

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $50.79 million. The Firm focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. It currently has negative earnings. The Firm offers QINPREZO , which is a product candidate for the treatment of acute myeloid leukemia (AML).

Among 4 analysts covering Cardinal Financial Corporation (NASDAQ:CFNL), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Cardinal Financial Corporation had 6 analyst reports since July 17, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, January 22 by Keefe Bruyette & Woods. As per Monday, August 22, the company rating was downgraded by Keefe Bruyette & Woods. As per Friday, August 19, the company rating was downgraded by Raymond James.

Investors sentiment decreased to 0 in 2016 Q4. Its down 1.10, from 1.1 in 2016Q3. It turned negative, as 16 investors sold CFNL shares while 45 reduced holdings. 16 funds opened positions while 46 raised stakes. 21.35 million shares or 1.81% less from 21.74 million shares in 2016Q3 were reported. Bank & Trust Of Montreal Can has invested 0.01% of its portfolio in Cardinal Financial Corporation (NASDAQ:CFNL). Independent Consultants invested 0.31% in Cardinal Financial Corporation (NASDAQ:CFNL). State Of Alaska Department Of Revenue has 3,560 shares. Wasatch Advisors Inc stated it has 0.05% of its portfolio in Cardinal Financial Corporation (NASDAQ:CFNL). State Board Of Administration Of Florida Retirement System holds 0% or 41,943 shares. Bnp Paribas Arbitrage Sa reported 60,937 shares stake. Burt Wealth Advsrs has invested 0.06% in Cardinal Financial Corporation (NASDAQ:CFNL). Citigroup holds 0.01% in Cardinal Financial Corporation (NASDAQ:CFNL) or 234,882 shares. Illinois-based Sphinx Trading LP has invested 0.25% in Cardinal Financial Corporation (NASDAQ:CFNL). 4,080 are held by First Mercantile Co. Bridgeway accumulated 0.02% or 49,478 shares. Moreover, Tributary Mgmt Limited Liability Corporation has 1.56% invested in Cardinal Financial Corporation (NASDAQ:CFNL) for 405,494 shares. Nationwide Fund Advsrs, Pennsylvania-based fund reported 23,100 shares. Wesbanco State Bank holds 111,348 shares. Moreover, Tiaa Cref Mgmt Limited Liability Com has 0% invested in Cardinal Financial Corporation (NASDAQ:CFNL).